Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v5-FR
Language French French
Date Updated 2018-03-16 2018-01-30
Drug Identification Number 00465283 00465283
Brand name HYDREA CAP 500MG HYDREA CAP 500MG
Common or Proper name Hydroxyurea Hydroxyurea
Company Name BRISTOL-MYERS SQUIBB CANADA BRISTOL-MYERS SQUIBB CANADA
Ingredients HYDROXYUREA HYDROXYUREA
Strength(s) 500MG 500MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 1 BTL x 100 1 BTL x 100
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-01-24 2018-01-24
Estimated end date 2018-03-16 2018-03-16
Actual end date 2018-02-09
Shortage status Resolved Actual shortage
Company comments The generic has been on back order since Aug. 2017. Currently we are only shipping stock for urgent need. The generic has been on back order since Aug. 2017. Currently we are only shipping stock for urgent need.
Health Canada comments